Wolverine Trading
ACAD icon

Wolverine Trading’s Acadia Pharmaceuticals ACAD Stock Holding History

Wolverine Trading’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-15,149
Closed -$316K – 4421
2023
Q3 		$316K Buy
+15,149
New +$411K ﹤0.01% 3235
2021
Q2 		– Sell
-26,042
Closed -$670K – 5724
2021
Q1 		$670K Buy
+26,042
New +$1.15M ﹤0.01% 3296
2020
Q1 		– Sell
-12,265
Closed -$529K – 4521
2019
Q4 		$529K Buy
+12,265
New +$534K ﹤0.01% 3021
2019
Q2 		– Sell
-10,848
Closed -$291K – 4330
2019
Q1 		$291K Sell
10,848
-5,343
-33% -$125K ﹤0.01% 3391
2018
Q4 		$253K Buy
+16,191
New +$314K ﹤0.01% 3398
2017
Q3 		– Sell
-12,711
Closed -$414K – 4336
2017
Q2 		$365K Sell
12,711
-29,343
-70% -$874K ﹤0.01% 2760
2017
Q1 		$1.43M Buy
42,054
+548
+1% +$19.3K 0.01% 1424
2016
Q4 		$1.2M Sell
41,506
-1,079
-3% -$28.5K 0.01% 1747
2016
Q3 		$1.39M Buy
+42,585
New +$1.44M 0.01% 1575

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Wolverine Trading's ACAD Position: Q4 2023 in Review

Wolverine Trading sold out of Acadia Pharmaceuticals (ACAD) in Q4 2023, closing a stake of 15,149 shares — an estimated $316K sold.

Wolverine Trading first reported a position in ACAD in Q3 2016 and held it in 9 quarters. The position peaked at $1.43M in Q1 2017. 276 funds tracked by Wall St. Rank hold ACAD as of Q4 2023.

  • Wolverine Trading reported no remaining Acadia Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Wolverine Trading sold 15,149 Acadia Pharmaceuticals shares in Q4 2023, an estimated $316K.
  • Wolverine Trading first reported a position in Acadia Pharmaceuticals in Q3 2016 and held it in 9 quarters.
  • Wolverine Trading's Acadia Pharmaceuticals position peaked at $1.43M in Q1 2017.
  • 276 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q4 2023.

Based on Wolverine Trading's 13F filing for Q4 2023, filed 14 Feb 2024.